Sahra-Amel Belambri

Sahra-Amel Belambri

Auto-generated profile, based on publicly available information

Sahra-Amel Belambri

Laboratoire de Biochimie Appliquée, Département de Biochimie, Faculté Des Sciences de La Nature Et de La Vie, Université Ferhat Abbes 1, Sétif, Algeria

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2026 in Food & Function
Verified
Journal Article
Closed access
PDF file
TRTinhinane Rekeb
Tinhinane Rekeb
SBSamia Bedouhene
Samia Bedouhene
NSNassima SENANI
Nassima SENANI
SBSahra-Amel Belambri
Sahra-Amel Belambri
MCMeriem- Dehbia Chabane
Meriem- Dehbia Chabane
Jamel El BennaJamel El Benna
Jamel El Benna
Orange peel aqueous extract and its major compound hesperidin inhibit neutrophil oxidative burst, MPO release, and chemotaxis, reducing inflammation in a rat pleurisy model.

11 November 2026 in Chemistry & Biodiversity
Verified
Journal Article
Open access
MCMeriem‐Dehbia Chabane
Meriem‐Dehbia Chabane
NSNassima SENANI
Nassima SENANI
SBSamia Bedouhene
Samia Bedouhene
SBSahra‐Amel Belambri
Sahra‐Amel Belambri
TRTinhinane Rekeb
Tinhinane Rekeb
Jamel El BennaJamel El Benna
Jamel El Benna
Bee venom (BV) is a complex bioactive mixture traditionally used to treat inflammatory disorders. This study investigated the biochemical composition and biological activities of BV from Algerian Apis mellifera intermissa using integrated in vitro, in vivo, and in silico approaches. BV was chemically characterized (UV–vis spectroscopy, SDS–PAGE, RP‐HPLC) and evaluated in vitro for anticoagulant (prothrombin time (PT), activated partial thromboplastin time (aPTT), thrombin time (TT)) and antioxidant (DPPH, ABTS, FRAP) activities. Anti‐inflammatory activity was assessed in rats using a carrageenan‐induced paw edema model following a 4‐week prophylactic protocol (0.8 mg/kg, twice weekly). Molecular docking was performed to investigate interactions between BV components and coagulation factors, including tissue factor, factor IXa, and factor Xa. BV contained 79.5% proteins, significantly prolonged aPTT from 23 ± 1.2 to 37.4 ± 1.8 s at 20 µg /mL, and exhibited moderate antioxidant activity (ABTS IC 50 = 67.6 ± 2.82 µg /mL). BV reduced paw edema by up to 86 ± 6% within the first hour, exceeding the effect of aspirin. Docking predicted favorable PLA2‐FXa interactions (HADDOCK score: −110 ± 8.4). These findings suggest the complementary biological activities of A. mellifera intermissa BV and its potential role as a multifunctional modulator of thrombo‐inflammatory pathways.